The FDA granted orphan drug designation to IOA-244 for the treatment of uveal melanoma, according to a press release from iOnctura.IOA-244 (roginolisib), a PI3K-delta inhibitor, is currently being assessed in the two-part phase 1 DIONE-01 trial, with p…
Month: January 2023
Global Progressive Lenses Market Report 2022 to 2027 – Rise of E-commerce as a Preferred Distribution Channel Contributes Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Progressive Lenses Market – Global Outlook & Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global progressive lenses market is expected to grow at a CAGR of 4.37% during 2021-2027….
VIDEO: Macular disease management unique in patients with advanced glaucoma
NEW YORK — In a presentation at OSN New York Retina, Rajendra S. Apte, MD, PhD, provides insight on managing macular and retinal diseases in patients with advanced glaucoma.“Sometimes in glaucoma patients, doing less and working with their glaucoma pro…
VisionSpring’s Screening Methodology Is Adopted by the World Health Organization to Increase Global Access to Reading Glasses
NEW YORK–(BUSINESS WIRE)–VisionSpring’s screening methodology has been adopted by the World Health Organization’s new open-access Training in Assistive Products (TAP). TAP equips primary healthcare providers, such as nurses and community health worke…
Bausch + Lomb Announces Participation at the 41st Annual J.P. Morgan Healthcare Conference
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation, (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced that Joseph C. Papa, chief executive officer, a…
Harrow Announces Availability of Fortisite™ Formulations for In-Office Use
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced the availability, for in-office use, of Fortisite™ (compounded Tobramycin 1.5% + Vancomycin 5%) from its FDA‑registered a…
Alcon Introduces a Premium, Reusable Toric Lens with Launch of TOTAL30 for Astigmatism
GENEVA–(BUSINESS WIRE)–Alcon Introduces a Premium, Reusable Toric Lens with Launch of TOTAL30 for Astigmatism
New Consensus on Thyroid Eye Disease Prompts Some Debate
The joint statement from the American Thyroid Association and European Thyroid Association offers appraisal of recent thyroid eye disease management for endocrinologists, with some debate on treatment. Medscape Medical News
Bausch + Lomb, Glaucoma Research Foundation launch education campaign
Bausch + Lomb and Glaucoma Research Foundation have launched the “Screen, Protect, Cure” campaign to raise glaucoma awareness.“Glaucoma can affect individuals of all ages, and only half of those affected are aware they have it, so it’s important that w…
The Worldwide Allergic Conjunctivitis Industry is Estimated to Reach $2.9 Billion by 2031 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Allergic Conjunctivitis Market By Drug Class, By Disease Type, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031” report has been added to ResearchAndMarkets.com’s offering. The global a…
Woman presents with monocular decrease in vision
A 30-year-old Indian woman was referred to the uveitis service with a chief complaint of decreased vision in the right eye for several months. She started having pain in the right eye with black flashes and headaches 4 months earlier.She was seen initi…
When should a patient with presbyopia switch from drops to a surgical treatment?
Click here to read the Cover Story, “Temporary, permanent solutions expand choices for presbyopia correction.”The decision to move to a permanent surgical treatment for presbyopia is an individual choice. It depends on the patient’s exams, their stage …
Temporary, permanent solutions expand choices for presbyopia correction
Few visual impairments have as far a reach as presbyopia.According to a 2018 study published in Ophthalmology, the global prevalence of presbyopia was about 25% in 2015. That is nearly 2 billion people with presbyopia across the world.“Anyone over the …
Surgeon shares how compounding has taken on large role in his cataract surgery practice
At Williamson Eye, we have converted to compounded intraoperative and postoperative medications for all our cataract surgery procedures. We also use compounded drugs for postoperative LASIK drops and some other indications.We find that these medication…
Never too late to ruin the case: How not to manage vitreous trouble with phaco-DMEK
This column is the latest article in the ongoing series “I wish I hadn’t done that.” Past submissions can be read here.This month’s edition of “I wish I hadn’t done that” is particularly painful, not only because of the recency of events, but also beca…
Lay managers: Your key to practice success
“There are no secrets to success. It is the result of preparation, hard work and learning from failure.” – Colin Powell“Effort only fully releases its reward after a person refuses to quit.” – Napoleon HillI returned recently from moderating an annual …
High POAG risk informs treatment for African American patients
In my first year at a primary care and specialty referral practice in Memphis, Tennessee, I have treated patients at every stage of glaucoma.Our patients come from Tennessee, Mississippi and Arkansas, all of which have above-average rates of diabetes, …
Demand will continue to grow for pharmacologic, lens-based presbyopia treatments
Presbyopia is the second most common refractive error we deal with as ophthalmologists, myopia being No. 1. Approximately 128 million people in the United States and 2 billion people globally have presbyopia.Most individuals manage their presbyopia wit…
Air-assisted cataract extraction assists with intraoperative Descemet’s detachment
Intraoperative Descemet’s detachment after the lens capsule is opened but before complete extraction of the nucleus/cortex can be challenging.Aborting surgery can cause severe phacoantigenic uveitis whereas continuing with surgery risks extension and/o…
Top five retina articles from 2022
Many of the year’s top retina articles focused on age-related macular degeneration.Read the top retina stories from 2022 below.FDA approves Vabysmo for treatment of wet AMD, DMEVabysmo (faricimab-svoa) from Genentech is an injectable eye medicine that …